InvestorsObserver is giving 4D Molecular Therapeutics Inc (FDMT) an Analyst Rating Rank of 73, meaning FDMT is ranked higher by analysts than 73% of stocks. The average price target for FDMT is $33.5 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating FDMT a Strong Buy today. Find out what this means to you and get the rest of the rankings on FDMT!